as on March 4, 2026 at 6:09 am IST
Day's Low
Day's High
1.29%
Downside
0.43%
Upside
52 Week's Low
52 Week's High
4.34%
Downside
28.89%
Upside
Check Sanofi market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$117.5B
EPS (TTM)
5.0079
Dividend Yield
3.62%
Quarterly Earnings Growth YOY
0.02%
PE Ratio (TTM)
20.45
Industry PE ratio
17.3774358974359
PEG Ratio
0.7319
EBITDA
12.6B
Revenue (TTM)
46.7B
Profit Margin
16.72%
Return On Equity TTM
6.66%
Track how Sanofi P/E has moved over time to understand its valuation trends.
Sanofi in the last 5 years
Lowest (8.47x)
December 31, 2023
Industry (17.38x)
March 3, 2026
Today (20.45x)
March 3, 2026
Highest (14.50x)
June 30, 2021
Today’s Price to Earnings Ratio: 20.45x
Compare market cap, revenue, PE, and other key metrics of Sanofi with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $117.5B | 4.84% | 20.45 | 16.72% | |
| BUY | $992.4B | 403.95% | 45.88 | 31.67% | |
| BUY | $323.2B | 332% | 31.82 | 17.41% | |
| BUY | $598.7B | 59.11% | 22.52 | 28.46% | |
| BUY | $410.4B | 119.53% | 97.92 | 6.91% |
The Sanofi stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Sanofi investment value today
Current value as on today
₹88,024
Returns
Returns from Sanofi Stock
Dollar Returns*
₹5,505 (+5.5%)
Based on 31 analysts
74.19%
Buy
22.58%
Hold
3.23%
Sell
Based on 31 analysts, 74.19% of analysts recommend a 'BUY' rating for Sanofi. Average target price of $57.68
Get share price movements and forecasts by analysts on Sanofi.
What analysts predicted
19.14%UPSIDE
Target Price
$57.68
Current Price
$46.64
Analyzed by
31 Analysts
Target
$57.68
Sanofi target price $57.68, a slight upside of 19.14% compared to current price of $46.64. According to 31 analysts rating.
Investment in Sanofi Shares on INDmoney has grown by 47.61% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:47.61% versus previous 30 day period
Search interest for Sanofi Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:20% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 03 March
Tue, 08:30 PM
-Japan grants orphan drug designation to Sanofi's Waylirz for IgG4-related disease, enhancing regulatory advantages.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, ASTRAZENECA PLC has given 167.7% return, outperforming this stock by 183.4%
Against Peers
![]()
In the last 3 years, Eli Lilly And Company has given 212.5% return, outperforming this stock by 212.7%
Revenue Fall
![]()
Sanofi's revenue has been declining for the past two quarters. It decreased from $13.17 billion to $12.20 billion, averaging a decline of 7.3% each quarter.
Profit Down
![]()
Sanofi's net profit has been declining for the last three quarters. It decreased from $3.94 billion to -$801 million, showing an average decrease of 78.7% each quarter.
Price Dip
![]()
In the last 1 year, SNY stock has moved down by -15.7%
| Organisation | Sanofi |
| Headquarters | 46, avenue de la Grande Armée, Paris, France, 75017 |
| Industry | Health Technology |
| CEO | Mr. Olivier Charmeil |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Madeleine Roach | Executive VP & Head of Business Operations |
Ms. Natalie Bickford | Executive VP & Chief People Officer |
Fabrizio Gaudi | Head of Austrian, German & Swiss Operations |
Mr. Thomas Triomphe | Executive Vice President of Vaccines |
Mr. Olivier Charmeil | Interim CEO & Executive VP of General Medicines |
Mr. François-Xavier Roger | Executive VP & CFO |
Mr. Thomas Kudsk Larsen | Head of Investor Relations & General Medicines |
Mr. Roy Papatheodorou | Executive VP & General Counsel |
Mr. Pierre Chancel | Senior Vice President of Global Diabetes and Senior Vice President of Global Marketing |
Mr. Erik Wallström | Head of Therapeutic Area - Neurology Development |
Sanofi share price today is $46.64 as on . Sanofi share today touched a day high of $46.84 and a low of $46.04.
Sanofi share touched a 52 week high of $60.12 on and a 52 week low of $44.62 on . Sanofi stock price today i.e. is trending at $46.64,which is 22.42% down from its 52 week high and 4.53% up from its 52 week low.
Sanofi market capitalisation is $0.12T as on .
Indian investors can start investing in Sanofi (SNY) shares with as little as ₹92.074 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹920.74 in Sanofi stock (as per the Rupee-Dollar exchange rate as on ).
Based on Sanofi share’s latest price of $46.64 as on March 4, 2026 at 12:39 am IST, you will get 0.2144 shares of Sanofi. Learn more about
fractional shares .
Sanofi stock has given 4.84% share price returns and 25.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?